CBTBasic Materials · Specialty ChemicalsThe 6 Wall Street analysts covering Cabot Corp. hold a median 12-month price target of $90 — +21.1% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 88 of 100 as at 22 Oct 2026 — inside the top quartile. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores Cabot Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Value (97): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.
Growth (23): Sales and profits are flat, shrinking, or growing more slowly than they were.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on CBT, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +21.1% from it.
Of the 20 most recent actions, 2 moved their price target up and 2 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 5 Oct 2026 | UBS | Maintains | Neutral | $92 → $86 |
| 7 Aug 2026 | JP Morgan | Maintains | Underweight | $70 → $78 |
| 7 Aug 2026 | JP Morgan | Maintains | Underweight | — |
| 5 Aug 2026 | UBS | Maintains | Neutral | $97 → $92 |
| 5 Aug 2026 | UBS | Maintains | Neutral | — |
| 25 June 2026 | Mizuho | Maintains | Neutral | $80 → $90 |
| 25 June 2026 | Mizuho | Maintains | Neutral | — |
| 8 June 2026 | Truist Securities | Initiates | Buy | — |
| 13 May 2026 | JP Morgan | Maintains | Underweight | — |
| 8 May 2026 | UBS | Maintains | Neutral | — |
| 6 May 2026 | Mizuho | Maintains | Neutral | — |
| 5 Feb 2026 | Mizuho | Downgrade | Neutral | — |
| 5 Feb 2026 | UBS | Maintains | Neutral | — |
| 12 Jan 2026 | UBS | Maintains | Neutral | — |
| 18 Dec 2025 | Mizuho | Maintains | Outperform | — |
| 28 Nov 2025 | JP Morgan | Maintains | Underweight | — |
| 17 Nov 2025 | Mizuho | Maintains | Outperform | — |
| 5 Nov 2025 | UBS | Maintains | Neutral | — |
| 3 Oct 2025 | Mizuho | Maintains | Outperform | — |
| 5 Aug 2025 | UBS | Maintains | Neutral | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
CBT appears in the Radar on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 22 Oct 2026, Cabot Corp. returned +7.2% against +15.6% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 36% of US stocks
Cheaper than 67% of US stocks
Cheaper than 38% of US stocks
Cheaper than 49% of US stocks
Higher than 43% of US stocks
Higher than 3% of US stocks
Higher than 19% of US stocks
Higher than 71% of US stocks
Higher than 60% of US stocks
Higher than 71% of US stocks
Higher than 90% of US stocks
Higher than 83% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Cabot Corp. has a market value of $3.8B and an enterprise value of $5.0B.
Revenue in the twelve months to 30 June 2026: $3.6B. The latest quarter grew 6.4% year on year.
Net income over the same four quarters: $228.0M, a 6.3% net margin.
Diluted earnings per share, trailing twelve months: $3.55.
Free cash flow in the twelve months to 30 June 2026: $281.0M.
Cabot Corp. spent $140.0M on share buybacks and $97.0M on dividends in the twelve months to 30 June 2026.
Trailing P/E: 20.6×; forward P/E: 10.5× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 2.58%, paying out 51% of earnings.
Cabot Corp. employs 4,064 people — $894K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Cabot Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
The item compares Cabot (CBT) and Carpenter Technology (CRS) with their sector’s performance so far this year.
Why it matters — It provides a year-to-date performance comparison relevant to readers tracking CBT against its sector and a peer.
Cabot Corporation will release its fourth-quarter fiscal 2026 operating results after market close on November 2, 2026. It will hold a conference call and live webcast to review the results at 8:00 a.m. ET on November 3.
Why it matters — CBT watchers can note the scheduled release and call dates for the company's upcoming quarterly results.
Zacks says Cabot's battery materials expansion, earnings outlook, cash generation and cost-cutting initiatives support expectations for sustained long-term growth.
Why it matters — These factors are relevant to CBT watchers assessing the company's growth outlook and financial performance.
Zacks Investment Research says its stock-selection approach centers on the Zacks Rank system, which emphasizes earnings estimates and estimate revisions, while also tracking value, growth, and momentum trends. The excerpt does not provide a specific assessment of Cabot’s valuation.
Why it matters — CBT watchers are given context on the investment factors Zacks considers, but no company-specific valuation conclusion is stated.
Cabot (CBT) and Carpenter Technology (CRS) are compared against their basic materials sector in a Zacks Investment Research piece examining year-to-date performance relative to the sector.
Why it matters — A Cabot watcher would care because the piece assesses how the stock is performing relative to its sector peers so far this year.
The 6 Wall Street analysts covering Cabot Corp. have a median 12-month price target of $90, with estimates ranging from $78 to $100. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 6 analysts covering Cabot Corp., 2 rate it a Buy, 3 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Cabot Corp. 88 out of 100 across roughly 4,600 US stocks as at 22 Oct 2026. None of this is personal advice — it does not consider your circumstances.
As at 22 Oct 2026, Cabot Corp. ranks 88 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (97 of 100).
No one can know that. What the data says: the median 12-month target from 6 analysts implies +21.1% from the last close, and Ticker Nerd's factor model ranks Cabot Corp. 88 out of 100 as at 22 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Cabot Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CBT are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $78 to $100 over the next 12 months.
Cabot Corp. returned +7.2% over the 12 months to 22 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Cabot Corporation develops and supplies a broad portfolio of advanced materials used in transportation, infrastructure, environment, consumer, electronics, and industrial applications.
The most recent item we track (Zacks Investment Research, 21 Oct 2026): "Is Cabot (CBT) Stock Outpacing Its Basic Materials Peers This Year?". The item compares Cabot (CBT) and Carpenter Technology (CRS) with their sector’s performance so far this year.
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Cabot Corporation develops and supplies a broad portfolio of advanced materials used in transportation, infrastructure, environment, consumer, electronics, and industrial applications. Its core offerings include reinforcing carbons, engineered elastomer composites, specialty carbons, conductive additives, battery materials, fumed metal oxides, masterbatches, conductive compounds, inkjet colorants, and aerogel. The company serves customers that rely on high-performance materials to improve durability, conductivity, reinforcement, dispersion, and insulation in finished products and manufacturing processes. Cabot Corporation operates through the Reinforcement Materials and Performance Chemicals segments, giving it exposure to both large-volume industrial markets and more specialized performance applications. With a focus on materials science and formulation expertise, Cabot Corporation plays an important role in supplying components that enhance product performance across multiple end markets.
CEO Ms. Erica J. McLaughlin C.P.A. · 4,064 employees · United States · https://www.cabotcorp.com
